MedTrace Logo

Passive Transmission of COVID-19 Antibody From Mother to Infant

NCT05851911 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-07-06

No results posted yet for this study

Summary

At present, there is no relevant research focusing on children's acquisition of novel coronavirus antibodies through maternal passive transmission. Therefore, this study assessed the changes of maternal passive transmission of COVID-19 antibodies by monitoring the specific antibodies of COVID-19 in young children; This will lay a foundation for further exploring the risk of COVID-19 infection in children and formulating immune prevention strategies.

Conditions

  • Passive Transmission of Maternal and Infant Antibodies

Interventions

BIOLOGICAL

sars-cov-2 vaccine or infection

Whether to vaccinate COVID-19 vaccine, or infect with sars-cov-2

Sponsors & Collaborators

  • Children's Hospital of Chongqing Medical University

    lead OTHER

Eligibility

Min Age
0 Months
Max Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-06-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05851911 on ClinicalTrials.gov